Illumina, Inc.

NASDAQ:ILMN

Medical - Diagnostics & Research

Healthcare
$210.01 +1.23%

+$1.95 today

Market cap
$31.75B
Beta
1.49
P/E (TTM)
28.9
EPS (TTM)
$5.58
52W Low $88.00High $177.22

Volume 1.63M

Average 1.65M

ILMN Income Before Tax

Profit after all operating and non-operating items but before income tax.

Illumina, Inc.NASDAQ: ILMN

Income Before Tax · Q2 FY2026 · quarter ended Jun 2026

Income before tax declines year over year

Q2 FY2026 income before tax of $260M fell 15.0% year over year, ahead of the -27.3% change in trailing-twelve-month income before tax. Sequentially, it rose 65.6% from the prior quarter.

Context

  • Income before tax amounted to 25.0% of revenue in FY2025, down 1.9 pp from a year earlier.
  • Income before tax increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -15.0% holds above the trailing-twelve-month pace of -27.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$260M+65.6% QoQ
Last fiscal yearDec 2025
$1.09B+192.1% YoY
LTMJun 2026
$1.02B-27.3% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-15.0%——
1 year+192.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
1.09B USD
Year-over-year change
+192.1%
4-year CAGR
+5.3%

Income Before Tax vs competitors

How ILMN compares with its peers on the latest reported figures

  • ILMN's LTM Jun 2026 income before tax of $1.02B is the highest of the 11 companies compared; the peer median is -$100.91M.
  • Its year-over-year change of -27.3% is the 9th highest of 11, against a peer median of -6.7%.
  • Income before tax amounts to 22.6% of revenue for ILMN, versus a peer median of 30.7%.
ILMN Competitors Peer median
Income Before Tax for ILMN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ILMNIllumina, Inc.LTM Jun 2026$1.02B -27.3%—22.6%
BLLNBillionToOne, Inc.LTM Jun 2026$37.91M +224.4%—9.5%
NEONeoGenomics, Inc.LTM Jun 2026-$54.55M +48.3%—7.1%
TXG10x Genomics, Inc.LTM Sep 2026-$65.16M +10.9%—10.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-$79.67M -23.0%—98.1%
PSNLPersonalis, Inc.LTM Mar 2026-$95.52M -13.7%—148.1%
WGSGeneDx Holdings Corp.LTM Jun 2026-$106.3M -7020.2%—23.4%
PACBPacific Biosciences of California, Inc.LTM Mar 2026-$127.77M +80.6%—79.8%
NTRANatera, Inc.LTM Jun 2026-$252.7M +0.3%—9.3%
MYGNMyriad Genetics, Inc.LTM Mar 2026-$399.8M -215.1%—48.2%
GHGuardant Health, Inc.LTM Sep 2026-$485.9M -22.2%—38.0%
Peer median (excluding ILMN) -$100.91M-6.7%—30.7%

Competitors are the stored peer set for ILMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jan 2022
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.53B4.58B4.5B4.37B4.34B
Cost of Revenue1.37B1.61B1.76B1.51B1.45B
Gross Profit3.15B2.97B2.74B2.86B2.89B
Gross Margin69.7%64.8%60.9%65.4%66.7%
Research & Development1.19B1.32B1.35B1.17B951M
Selling, General & Admin2.09B1.3B1.61B1.09B1.08B
Operating Expenses3.28B7.15B3.81B3.69B2.03B
Depreciation & Amortization251M394M432M354M270M
EBITDA1.2B(3.92B)(608M)(725M)1.46B
EBITDA Margin26.4%-85.4%-13.5%-16.6%33.6%
Operating Income(123M)(4.18B)(1.07B)(833M)864M
Operating Margin-2.7%-91.2%-23.7%-19.1%19.9%
Interest Income011M58M46M40M
Interest Expense61M26M77M100M101M
Other Income / Expenses1.01B(157M)(48M)(346M)222M
Income Before Tax884M(4.34B)(1.12B)(1.18B)1.09B
Pre-Tax Margin19.5%-94.6%-24.8%-27.0%25.0%
Income Tax Expense122M68M44M44M236M
Net Income762M(4.4B)(1.16B)(1.22B)850M
Net Margin16.8%-96.1%-25.8%-28.0%19.6%
EPS (Basic)5.08(28.05)(7.35)(7.69)5.48
EPS (Diluted)5.05(28.05)(7.35)(7.69)5.45
Weighted Avg Shares150M157M158M159M155M
Weighted Avg Shares (Diluted)151M157M158M159M156M

Illumina, Inc.

NASDAQ:ILMN

Intrinsic Alpha fair value

Locked

Current Price

$210.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.